42
Pharma & HealthcareAvoid
ABSL Pharma And Healthcare
Aditya Birla Sun Life · Direct–Growth · rank #12 of 19 by Smart Score
Data updated
Trailing returns
1 Year
10.6%
+15.3% vs index
3 Years
18.9%
+9.5% vs index
5 Years
12.9%
+5.0% vs index
Since launch
20.1%
Year-by-year performance
2021
+21.4%-9.3% vs index
2022
-11.3%-15.1% vs index
2023
+39.6%+13.0% vs index
2024
+37.7%+22.0% vs index
2025
-3.1%-10.8% vs index
2026
+12.2%+18.2% vs index
Why this score
ABSL Pharma And Healthcare scores 42/100 — #12 of 19 Pharma & Healthcare fund (Avoid). It stands out for sortino ratio — beating 63% of peers on sortino ratio. The main drag is its 5y return (better than only 28% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return12.89% · 28th percentile in category
3Y return18.90% · 38th percentile in category
Alpha2.61 · 28th percentile in category
Sortino ratio1.37 · 63rd percentile in category
Expense ratio1.07% · 42nd percentile in category
Fund size1077.52 Cr · 55th percentile in category
Top holdings
1.Torrent Pharmaceuticals Ltd9.28%
2.Sun Pharmaceutical Industries Ltd8.61%
3.Apollo Hospitals Enterprise Ltd6.44%
4.Cipla Ltd6.38%
5.Aurobindo Pharma Ltd4.52%
39 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.